EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Burden of illness and treatment attitudes among participants meeting Rome IV criteria for irritable bowel syndrome: A nationwide survey in the United States

Brian E Lacy iD, Yanqing Xu, Douglas C A Taylor, Katherine J Kosch, Rachel Dobrescu, Amy Morlock, Robert Morlock, Ceciel Rooker

Neurogastroenterology & Motility · 2024

DOI: 10.1111/nmo.14903 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurogastroenterology & Motility, 2024. Verfasst von Brian E Lacy und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, USA. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Cost of Illness. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ironwood Pharmaceuticals, Inc., AbbVie Inc., Ironwood Pharmaceuticals, Incorporated.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Irritable bowel syndrome (IBS) is a disorder of gut–brain interaction characterized by abdominal pain and altered bowel habits, with patient‐perceived dissatisfaction of treatment symptom control. We assessed disease burden, satisfaction with medication use, and impact on activities, in participants with IBS with constipation (IBS‐C) and diarrhea (IBS‐D).

Methods

This study assessed data from a large, United States survey of adults querying demographics, comorbid conditions, quality of life, medication use, satisfaction with symptom control, and work productivity. Participants were grouped into the IBS‐C or IBS‐D cohort if they met Rome IV criteria, with controls matched 1:1 according to age, sex, race, region, and Charlson Comorbidity Index score. All data were self‐reported. Key Results Nine hundred and ten participants with IBS‐C and 669 with IBS‐D were matched to controls. The most reported symptoms were abdominal discomfort for IBS‐C and abdominal pain and abdominal discomfort for IBS‐D. Among the IBS‐C and IBS‐D cohorts, 74.2% and 65.9%, respectively, took prescription and/or over‐the‐counter medication for their symptoms. Respondents were more dissatisfied than satisfied with control of their symptoms. Respondents taking prescription medication(s) with or without over‐the‐counter medication(s) reported better symptom control than respondents only taking over‐the‐counter medications ( p < 0.001). There was significantly higher mean presenteeism, work productivity loss, and daily activity impairment ( p < 0.001 for all) in respondents with IBS compared with controls. Conclusions and Inferences This study provides insight into respondents' experiences of IBS symptoms, including the impact on daily activity, as well as satisfaction with control of symptoms and prescription and over‐the‐counter medications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Irritable Bowel SyndromeCost of IllnessHumansFemaleMaleAdultUnited StatesMiddle AgedQuality of LifePatient SatisfactionAgedConstipationYoung AdultDiarrheaAdolescent

Stichwörter der Autor:innen

abdominal painconstipationdiarrheafunctional GI diseasesirritable bowel syndrome (IBS)

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, USA.
  • AbbVie Inc, North Chicago, Illinois, USA.
  • Former employee of Ironwood Pharmaceuticals, Boston, Massachusetts, USA.
  • Acumen Health Research Institute, Ann Arbor, Michigan, USA.
  • YourCareChoice, Ann Arbor, Michigan, USA.
  • International Foundation for Gastrointestinal Disorders, Milwaukee, Wisconsin, USA.

ORCID-Profile: Brian E Lacy

Förderung

  • Ironwood Pharmaceuticals, Inc.
  • AbbVie Inc.
  • Ironwood Pharmaceuticals, Incorporated
  • AbbVie

Zitieren

APA

Lacy, B. E., Xu, Y., Taylor, D. C. A., Kosch, K. J., Dobrescu, R., Morlock, A., Morlock, R., & Rooker, C. (2024). Burden of illness and treatment attitudes among participants meeting Rome IV criteria for irritable bowel syndrome: A nationwide survey in the United States. Neurogastroenterology & Motility. https://doi.org/10.1111/nmo.14903

Vancouver

Lacy BE, Xu Y, Taylor DCA, Kosch KJ, Dobrescu R, Morlock A, et al. Burden of illness and treatment attitudes among participants meeting Rome IV criteria for irritable bowel syndrome: A nationwide survey in the United States. Neurogastroenterology & Motility. 2024. doi:10.1111/nmo.14903

BibTeX
@article{Lacy2024,
  author = {Lacy, Brian E and Xu, Yanqing and Taylor, Douglas C A and Kosch, Katherine J and Dobrescu, Rachel and Morlock, Amy and Morlock, Robert and Rooker, Ceciel},
  title = {Burden of illness and treatment attitudes among participants meeting Rome IV criteria for irritable bowel syndrome: A nationwide survey in the United States},
  journal = {Neurogastroenterology & Motility},
  year = {2024},
  doi = {10.1111/nmo.14903}
}
Kostenlos starten →